Home/Filings/4/0001140361-18-015300
4//SEC Filing

GLUCK FREDERICK W 4

Accession 0001140361-18-015300

CIK 0001501989other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 8:54 PM ET

Size

7.0 KB

Accession

0001140361-18-015300

Insider Transaction Report

Form 4
Period: 2018-03-26
Transactions
  • Sale

    Common Stock

    2018-03-26$31.93/sh5,000$159,642271,643 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By LLC)
    22,111
  • Common Stock

    (indirect: By Spouse)
    3,200
Footnotes (4)
  • [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.70 to $32.18, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
  • [F4]Richlin Partners, LLC is an entity owned of record by the spouse of the Reporting Person.

Documents

1 file

Issuer

CytomX Therapeutics, Inc.

CIK 0001501989

Entity typeother

Related Parties

1
  • filerCIK 0001184126

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 8:54 PM ET
Size
7.0 KB